by drgitt | Jun 7, 2021 | Uncategorized
For Immediate Release: June 07, 2021 Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway,...
by drgitt | Jun 3, 2021 | Uncategorized
People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer. Ewen Callaway A bone-marrow plasma cell (artificially coloured). Such cells, which...
